Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.
2.

The Overuse, Underuse, and Misuse of Dialysis in ESKD Patients with Dementia.

MacPhail A, Ibrahim JE, Fetherstonhaugh D, Levidiotis V.

Semin Dial. 2015 Sep-Oct;28(5):490-6. doi: 10.1111/sdi.12392. Epub 2015 May 21. Review.

PMID:
25997680
3.

Estimated GFR reporting influences recommendations for dialysis initiation.

Brimble KS, Mehrotra R, Tonelli M, Hawley CM, Castledine C, McDonald SP, Levidiotis V, Gangji AS, Treleaven DJ, Margetts PJ, Walsh M.

J Am Soc Nephrol. 2013 Nov;24(11):1737-42. doi: 10.1681/ASN.2013010035. Epub 2013 Aug 29.

4.

An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.

Shahir AK, Briggs N, Katsoulis J, Levidiotis V.

Nephrology (Carlton). 2013 Apr;18(4):276-84. doi: 10.1111/nep.12044.

PMID:
23441694
5.

Increase in nephrology advanced trainee numbers in Australia and associated reduction in clinical exposure over the past decade.

Amos L, Toussaint ND, Phoon RK, Elias TJ, Levidiotis V, Campbell SB, Walker AM, Harrex C.

Intern Med J. 2013 Mar;43(3):287-93. doi: 10.1111/j.1445-5994.2012.02839.x.

PMID:
22646703
6.

Corticosteroids worsen proteinuria and increase intraglomerular signaling by NF-ĸB in a model of membranous glomerulonephritis.

Mudge SJ, Paizis K, Auwardt RB, Levidiotis V, Fraser SA, Power DA.

Nephron Exp Nephrol. 2010;116(2):e23-31. doi: 10.1159/000317128. Epub 2010 Jun 29.

PMID:
20588061
7.

Pregnancy and maternal outcomes among kidney transplant recipients.

Levidiotis V, Chang S, McDonald S.

J Am Soc Nephrol. 2009 Nov;20(11):2433-40. doi: 10.1681/ASN.2008121241. Epub 2009 Sep 24.

8.

Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.

Velkoska E, Dean RG, Burchill L, Levidiotis V, Burrell LM.

Clin Sci (Lond). 2010 Feb;118(4):269-79. doi: 10.1042/CS20090318.

9.

Live kidney donors - assessment and follow up.

Levidiotis V.

Aust Fam Physician. 2009 May;38(5):316-20. Review.

10.

Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells.

Cook N, Fraser SA, Katerelos M, Katsis F, Gleich K, Mount PF, Steinberg GR, Levidiotis V, Kemp BE, Power DA.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F801-9. doi: 10.1152/ajprenal.90372.2008. Epub 2009 Jan 28.

11.

Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.

Ko H, Hambly BD, Eris JM, Levidiotis V, Wyburn K, Wu H, Chadban SJ, Yin JL.

Transpl Immunol. 2008 Nov;20(1-2):99-105. doi: 10.1016/j.trim.2008.07.001. Epub 2008 Jul 26.

PMID:
18662782
12.

Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.

Burchill L, Velkoska E, Dean RG, Lew RA, Smith AI, Levidiotis V, Burrell LM.

Exp Physiol. 2008 May;93(5):622-30. doi: 10.1113/expphysiol.2007.040386. Epub 2008 Jan 25.

13.

Predictors of early dialysis vascular-access failure after thrombolysis.

Crikis S, Lee D, Brooks M, Power DA, Ierino FL, Levidiotis V.

Am J Nephrol. 2008;28(2):181-9. Epub 2007 Oct 24.

PMID:
17960056
14.

New approaches to the treatment of dense deposit disease.

Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group.

J Am Soc Nephrol. 2007 Sep;18(9):2447-56. Epub 2007 Aug 5. Review.

15.

Heparanase in glomerular diseases.

van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J.

Kidney Int. 2007 Sep;72(5):543-8. Epub 2007 May 23. Review.

16.

Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK).

Fraser SA, Gimenez I, Cook N, Jennings I, Katerelos M, Katsis F, Levidiotis V, Kemp BE, Power DA.

Biochem J. 2007 Jul 1;405(1):85-93.

17.
18.

Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells.

Kanellis J, Kandane RK, Etemadmoghadam D, Fraser SA, Mount PF, Levidiotis V, Kemp BE, Power DA.

Immunol Cell Biol. 2006 Feb;84(1):6-12.

PMID:
16405649
19.

Tubulointerstitial nephritis and uveitis syndrome: sore eyes and sick kidneys.

Lim AK, Roberts MA, Lim Joon T, Levidiotis V.

Med J Aust. 2005 Nov 7;183(9):477-8. No abstract available.

PMID:
16274351
20.

An unexpected cause of macroscopic haematuria.

Lubel JS, Burrell LM, Levidiotis V.

Med J Aust. 2005 Sep 19;183(6):321-3.

PMID:
16167874
21.

Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177.

Mount PF, Hill RE, Fraser SA, Levidiotis V, Katsis F, Kemp BE, Power DA.

Am J Physiol Renal Physiol. 2005 Nov;289(5):F1103-15. Epub 2005 May 24.

22.

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA.

Nephrology (Carlton). 2005 Apr;10(2):167-73.

PMID:
15877677
23.

New insights into the molecular biology of the glomerular filtration barrier and associated disease.

Levidiotis V, Power DA.

Nephrology (Carlton). 2005 Apr;10(2):157-66. Review.

PMID:
15877676
24.

Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality.

Fraser S, Mount P, Hill R, Levidiotis V, Katsis F, Stapleton D, Kemp BE, Power DA.

Am J Physiol Renal Physiol. 2005 Mar;288(3):F578-86. Epub 2004 Nov 9.

25.

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.

Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA.

J Am Soc Nephrol. 2004 Nov;15(11):2882-92.

26.

A study of VEGF and its receptors in two rat models of proteinuria.

Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA.

Nephron Physiol. 2004;96(1):P26-36.

PMID:
14752241
27.

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.

Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA.

J Am Soc Nephrol. 2004 Jan;15(1):68-78.

28.

Increased expression of heparanase in puromycin aminonucleoside nephrosis.

Levidiotis V, Kanellis J, Ierino FL, Power DA.

Kidney Int. 2001 Oct;60(4):1287-96.

Supplemental Content

Loading ...
Support Center